Pathos AI, a leading AI-enabled biotech company focused on transforming drug development in oncology, today announced the appointment of Iker Huerga as Chief Executive Officer and Board Member. Huerga ...

Pathos AI has launched a $400 million funding round and already raised nearly $283 million. The Chicago-based startup formed ...

Anyone who’s shed a tear (or a thousand) during Sarah McLachlan’s ASPCA commercial knows that as much as we might like to think of ourselves as purely logical beings, we’re often driven by ...

Vince Vaughn, in this sincere dramedy, plays a man who opens a restaurant that aims to offer authentic flavors by employing ...

Tempus AI continued to see dramatic revenue and gross profit growth in the first quarter of 2025, with year-over-year revenue ...

Julia Garner, who will portray Shalla-Bal / Silver Surfer in the upcoming superhero feature The Fantastic Four: First Steps, ...

Aptly titled Evolución, Grupo Firme pushes its norteño/banda boundaries to showcase a more nuanced sound in its new album, ...

Is it wrong for a biopic about a real-life serial killer to have any level of sympathy or pathos towards the murderer? Or it that simply disrespectful?

The biggest strategic highlight for Tempus AI Inc. (NASDAQ: TEM) during the first quarter was a multi-million dollar deal to build "the world's largest foundation model for oncology." ...

Performers have been rehearsing for a show which combines William Shakespeare's A Midsummer Night's Dream with wrestling.

AstraZeneca, Tempus and Pathos will develop an AI-driven foundational model to develop therapeutics in oncology.